Chemosensitisation by the more selective CHK1 inhibitors may be more dependent on the p53 status of the tumour cells but many studies were conducted in only p53 dysfunctional cells, without p53 functional ones as control, so the dependence on p53 dysfunction cannot be conclusively ascertained. Here, CHEK1 is linked to neoplasm.